NCT05266885

Brief Summary

Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequently associated with diabetes mellitus. Therefore, the detection and management of elevated blood pressure (BP) is a critical component of the comprehensive clinical management of diabetics. Since the rates of hypertension in diabetics are lacking in Afghanistan, this study aimed to evaluate the prevalence of elevated blood pressure in type-2 diabetic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
322

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2020

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

February 20, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
Last Updated

March 4, 2022

Status Verified

March 1, 2022

Enrollment Period

2 months

First QC Date

February 20, 2022

Last Update Submit

March 3, 2022

Conditions

Prevalence of Elevated Blood Pressure in Type-2 Diabetics

Keywords

Prevalence; Hypertension; Type-2 diabetes

Outcome Measures

Primary Outcomes (1)

  • High incidence of HTN in Diabetics

    3 months

Study Arms (1)

Male and Female

(37 male, 63 female)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All Type -2 diabetics who were presented to our center from November 2019 to January 2020.

You may qualify if:

  • Clinically diagnosed diabetic patients
  • Newly diagnosed Diabetics
  • known case of diabetes

You may not qualify if:

  • The patients who were seriously ill
  • Pregnant women
  • Type-1 diabetic patients,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Habib Ahmad Esmat

Kabul, None Selected, 35030, Afghanistan

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Mohammad wali Nasary, MD

    KMUs

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research committee

Study Record Dates

First Submitted

February 20, 2022

First Posted

March 4, 2022

Study Start

November 1, 2019

Primary Completion

January 1, 2020

Study Completion

January 30, 2020

Last Updated

March 4, 2022

Record last verified: 2022-03

Locations

AF(1)